Q: WHAT WERE THE RESULTS OF THE WOMEN'S HEALTH INITIATIVE STUDY?
A: According to these results, estrogen used in combination with progestin increases the risk of both heart disease and breast cancer, strokes and blood clots. The Women's Health Initiative concluded definitively that hormone replacement therapy places women at a significantly elevated risk for breast cancer. The study found a 26 percent increase in breast cancer risk for women taking hormone replacement therapy. The study also showed that, contrary to prevailing belief, hormone replacement therapy also placed women using hormone replacement therapy at a higher risk - 29 percent - for heart disease. The Women's Health Initiative study on the combination of estrogen and progestin halted five years into the eight-year study because researchers determined that the risks to women in study outweighed any benefits. The arm of the trial studying estrogen alone continues and the results of that portion of the study are not yet known.
Q: DOES HORMONE REPLACEMENT THERAPY PREVENT OSTEOPOROSIS?
A: Yes and no. Although hormone replacement therapy has shown to slow bone loss, those effects are not permanent and stop when women discontinue hormone replacement therapy. Because of the risks, hormone replacement therapy is no longer recommended for the prevention of osteoporosis.
A: According to these results, estrogen used in combination with progestin increases the risk of both heart disease and breast cancer, strokes and blood clots. The Women's Health Initiative concluded definitively that hormone replacement therapy places women at a significantly elevated risk for breast cancer. The study found a 26 percent increase in breast cancer risk for women taking hormone replacement therapy. The study also showed that, contrary to prevailing belief, hormone replacement therapy also placed women using hormone replacement therapy at a higher risk - 29 percent - for heart disease. The Women's Health Initiative study on the combination of estrogen and progestin halted five years into the eight-year study because researchers determined that the risks to women in study outweighed any benefits. The arm of the trial studying estrogen alone continues and the results of that portion of the study are not yet known.
Q: DOES HORMONE REPLACEMENT THERAPY PREVENT OSTEOPOROSIS?
A: Yes and no. Although hormone replacement therapy has shown to slow bone loss, those effects are not permanent and stop when women discontinue hormone replacement therapy. Because of the risks, hormone replacement therapy is no longer recommended for the prevention of osteoporosis.
No comments:
Post a Comment